VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection
Clinical trial NCT01241760 · COMPLETED
Trial details
- NCT number
- NCT01241760
- Sponsor
- Janssen Infectious Diseases BVBA
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2012-08-01
- Enrollment
- 744
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.